ForeverLabs
0%
ClinicalStroke recoveryStroke

Autologous mesenchymal stem cell transplantation in stroke patients

Wiley

Key Findings

Changes in neurological deficits and improvements in function were compared between two groups for 1 year after symptom onset.

Patients treated with autologous MSCs showed significant improvement in both cognition and mobility.

AI generated image for: Autologous mesenchymal stem cell transplantation in stroke patients

Changes in neurological deficits and improvements in function were compared between two groups for 1 year after symptom onset. Patients treated with autologous MSCs showed significant improvement in both cognition and mobility.

Research Details

Source

Wiley

Publication Date
Categories & Tags
ClinicalStroke recoveryStroke
View Original Publication

Cite this article: Wiley. "Autologous mesenchymal stem cell transplantation in stroke patients". Published August 11, 2025. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.20501

Access Original Research

View the complete study and detailed methodology from the original source.

Read Full Study↗
← All Articles← Clinical Articles

You Might Also Like

Explore more articles in this category

AI generated image for: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
1 min

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial

This phase II randomized trial demonstrates that autologous hematopoietic stem cell transplantation (AHSCT) is significantly more effective than mitoxantrone at reducing MRI-detected disease activity in patients with aggressive multiple sclerosis. Results showed a 79% reduction in new T2 lesions and a significant decrease in relapse rates, supporting the need for larger phase III clinical trials.

Neurology
AI generated image for: Effect of aging on stem cells
1 min

Effect of aging on stem cells

As we age, stem cells lose efficacy and ability to heal.

NIH
AI generated image for: Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
1 min

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease

Intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) successfully improved cognitive function and prevented neurodegeneration in two different Alzheimer's disease mouse models.

PubMed